Three years later, a significant amount of that plaque is gone
However, a 2025 meta-analysis, which included more than 84,000 participants across 34 studies, found that people taking GLP-1s were 3.4 times more likely to experience hair loss compared with people not taking the drugs
Today I learned that there is an entire ecosystem of companies selling peptides like Semaglutide and other GLP-1 agonists under the label of research chemicals. No prescription, no physician oversight, just a quick online checkout and a disclaimer: not for human use
Athauda D, Maclagan K, Budnik N, Zampedri L, Hibbert S, Skene SS, Chowdhury K, Aviles-Olmos I, Limousin P, Foltynie T
Safety Considerations and When Arm Injections May Not Be Ideal Arm injections are appropriate for most patients but may present challenges in certain situations: limited subcutaneous fat, difficulty self-administering, or history of lipohypertrophy in previous arm injection sites